PTC Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTCT and other ETFs, options, and stocks.About PTCT
PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in Warren, NJ.
PTCT Key Statistics
Stock Snapshot
As of today, PTC Therapeutics(PTCT) shares are valued at $76.85. The company's market cap stands at 6.17B, with a P/E ratio of 9.03.
During the trading session on 2026-01-08, PTC Therapeutics(PTCT) shares reached a daily high of $77.39 and a low of $75.65. At a current price of $76.85, the stock is +1.6% higher than the low and still -0.7% under the high.
Trading activity shows a volume of 1.45M, compared to an average daily volume of 1.1M.
Over the past 52 weeks, PTC Therapeutics(PTCT) stock has traded between a high of $87.50 and a low of $35.95.
Over the past 52 weeks, PTC Therapeutics(PTCT) stock has traded between a high of $87.50 and a low of $35.95.
PTCT News
Morgan Stanley raised the firm’s price target on PTC Therapeutics (PTCT) to $90 from $78 and keeps an Overweight rating on the shares. The firm sees a continuat...
Recently, PTC Therapeutics amended its royalty purchase agreement with Royalty Pharma to fully monetize a non-core royalty asset for an upfront US$240 million p...
PTC Therapeutics (PTCT) has drawn investor attention after recent trading left the share price at US$76.74. This has prompted a closer look at how its rare dise...
Analyst ratings
60%
of 15 ratingsMore PTCT News
New insider activity at PTC Therapeutics ( (PTCT) ) has taken place on January 2, 2026. Claim 70% Off TipRanks This Holiday Season Unlock hedge fund-level data...